23.01USD+0.83%Mkt Cap: 1.18B USDP/E: —Last update: 2026-06-01
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap1.18B USD
Enterprise Value1.02B USD
Revenue (TTM)412.82M USD
Gross Profit256.57M USD
Net Income (TTM)-21.35M USD
Revenue/Share7.899 USD
Last Price23.01 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees761
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS14167L1035
Valuation
P/E (Trailing)—
P/E (Forward)20.12
PEG—
EV/EBITDA438.77
EV/Revenue2.46
P/S2.86
P/B3.73
EPS (TTM)-0.16
EPS (Forward)1.13
52W Range
10.9698% of range23.24
52W High23.24 USD
52W Low10.96 USD
Profitability
Gross Margin67.55%
Oper. Margin1.53%
EBITDA Margin0.56%
Profit Margin-5.62%
ROE-7.05%
ROA-5.17%
Growth
Revenue Growth39.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF42.03M USD
CapEx (TTM)6.59M USD
FCF Margin16.99%
FCF Yield5.93%
Net Debt-162.68M USD
Net Debt/EBITDA-70.24
Balance Sheet
Debt/Equity0.09
Current Ratio3.40
Quick Ratio2.93
Book Value/Sh6.115 USD
Cash/Share3.623 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)25.80 USD
Target Range21.00 USD – 28.00 USD
# Analysts5
Ownership
Shares Out.51.66M
Float49.29M
Insiders3.38%
Institutions101.86%
Short Interest
Short Ratio8.2d
Short % Float12.83%
Short % Out.12.60%
Shares Short6.51M
Short (prev mo.)6.40M
Technical
SMA 5019.69 (+16.9%)
SMA 20017.55 (+31.1%)
Beta2.49
S&P 52W Chg27.94%
Avg Vol (30d)640.49K
Avg Vol (10d)682.85K
Technical Indicators
RSI (14)65.6
MACD0.6176
MACD Signal0.5025
MACD Hist.+0.1151
BB Upper22.80 USD
BB Middle21.31 USD
BB Lower19.81 USD
BB Width14.03%
ATR (14)1.095 USD
Vol Ratio (20d)0.53x